Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)
The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).
Breast Cancer
DRUG: neratinib|OTHER: Placebo|DRUG: Moxifloxacin
QTc interval, 3 days
The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).